Solazyme (SZYM -0.5%) is upgraded to Buy with a $15 price target by ThinkEquity, which predicts...

|By:, SA News Editor

Solazyme (SZYM -0.5%) is upgraded to Buy with a $15 price target by ThinkEquity, which predicts the company will develop strong new products via the strength of its partners and positive track record. The firm doesn't expect SZYM to profitably sell its oil made from sugar but is upbeat about its skin care, nutrition, chemical and fuel products.